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Background: Metastatic lung cancer is one of the leading causes of cancer death. In recent years, epithelial-
to-mesenchymal transition (EMT) has been found to contribute to metastasis, as it enables migratory and invasive
properties in cancer cells. Previous genome-wide studies found that DNA methylation was unchanged during EMT
induced by TGF-β in AML12 cells. In this study, we aimed to discover EMT-related changes in DNA methylation in
cancer cells, which are poorly understood.
Methods: We employed a next-generation sequencing-based method, MSCC (methyl-sensitive cut counting), to
investigate DNA methylation during EMT in the A549 lung cancer cell line.
Results: We found that methylation levels were highly correlated to gene expression, histone modifications and
small RNA expression. However, no differentially methylated regions (DMRs) were found in A549 cells treated with
TGF-β for 4 h, 12 h, 24 h and 96 h. Additionally, CpG islands (CGIs) showed no overall change in methylation levels,
and at the single-base level, almost all of the CpGs showed conservation of DNA methylation levels. Furthermore,
we found that the expression of DNA methyltransferase 1, 3a, 3b (DNMT1, DNMT3a, DNMT3b) and ten-eleven
translocation 1 (TET1) was altered after EMT. The level of several histone methylations was also changed.
Conclusions: DNA methylation-related enzymes and histone methylation might have a role in TGF-β-induced
EMT without affecting the whole DNA methylome in cancer cells. Our data provide new insights into the global
methylation signature of lung cancer cells and the role of DNA methylation in EMT.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1112892497119603
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Lung cancer is one of the most common causes of
cancer-related death [1]. In recent years, the expression
and mutation of multiple genes have been shown to have
a relationship with lung cancer [2-4]. Notably, metastasis
and the related genetic and epigenetic changes are the
main cause of the high death rate from lung cancer [5].* Correspondence: lxzhan@sibs.ac.cn; superliuyun@gmail.com
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unless otherwise stated.The migratory and invasive properties imparted by EMT
(epithelial-to-mesenchymal transition) are known to be
essential for metastasis [6]. EMT is characterized by
the loss of cell-cell adhesion and other cell junctions,
the loss of cell polarity, and the re-organization of the
actin cytoskeleton. EMT is involved in metastasis in a
variety of cancers, e.g., lung cancer [7], breast cancer [8]
and prostate cancer [9]. Understanding the mechanisms
of EMT may be a key approach for developing new
therapeutic strategies for inhibiting tumor metastasis.
Methylation of DNA cytosine residues (5mC) has
been proven to play important roles in many biological
processes, such as embryonic development, organismalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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focused on 5mC in the CpG (C-phosphate-G) context
[11]. Mammalian genomes are dominated by methylated
CpGs, while there are also some hypomethylated domains,
called CpG islands (CGIs), found at the 5′ region of genes,
promoters and first exons [12]. CGIs are short CpG-rich
regions with low methylation levels [13]. Many studies
have shown that DNA methylation is associated with gene
expression. Methylation of CGIs at transcription start sites
(TSSs) is believed to contribute to gene silencing, and
approximately 60% of human genes have CGI promoters
[14], while methylation of CpGs in the gene body is
positively correlated with gene expression [15], as it may
correspond with elongation. Several histone modifications,
such as H3K4me3, also have a role in the regulation of
gene expression and cooperate with DNA methylation.
Additionally, histone modifications help to direct DNA
methylation patterning [16]. The ten-eleven translocation
(TET) family of enzymes was recently found to catalyze
the oxidation of 5mC to 5-hydroxymethylcytosine (5hmC),
which might represent an intermediate form of an
active DNA demethylation process and regulate gene
expression [17].
The involvement of DNA methylation in EMT has
long been considered. Hypermethylation in the promoter
region was found to be one of the key factors that lead
to reduced mRNA expression of E-cadherin during EMT
[18]. Several genome-wide studies of global epigenetic
changes during EMT have also been performed. Hundreds
of genes showed EMT-associated changes in DNA methy-
lation in EP156T cells, while there was no significant
correlation between DNA methylation changes and changes
in gene expression [19]. After induction with TGF-β,
AML12 cells showed characteristics of EMT, but the
genome-wide DNA methylation pattern was unchanged
[20]. The relationship between global DNA methylation
and EMT in cancer cells has not been revealed.
Here, to investigate possible EMT-related changes in
DNA methylation in cancer cells, we employed MSCC
(methyl-sensitive cut counting) to perform a genome-wide
DNA methylation analysis in A549 lung cancer cells
before and after EMT. We report the relationship between
DNA methylation, histone modifications and gene expres-
sion in lung cancer cells, and we describe the weak effect
of EMT on the whole DNA methylome. We also suggest
that DNMTs (DNA methyltransferases), TETs and histone
methylation patterns might have roles in TGF-β-induced
EMT in cancer cells.
Methods
Cell culture and inducement of EMT
The A549 cell line was obtained from Mr. Ji Hongbin
(Shanghai Institute for Biological Sciences, Chinese Acad-
emy of Sciences, Shanghai, China) and was maintained inRPMI 1640 medium supplemented with 10% FBS in a
37°C incubator with a humidified atmosphere of 5% CO2.
TGF-β was purchased from R&D Systems (R&D Systems
Inc., Minneapolis, MN, USA), and cells were treated at the
time indicated with 5 ng/ml in culture medium to induce
EMT. We repeated the experiments, including cell harvest
followed by RT-PCR, Western blotting and DNA extrac-
tion, three times for each time point.
Cell lysis and western blotting
Cells were rinsed with ice-cold PBS, were lysed in radio-
immunoprecipitation assay (RIPA) buffer (CST, #9806)
containing complete protease inhibitors (Roche), phos-
phatase inhibitors (Roche), 5 mM DTT (Sigma) and 1 mM
PMSF, and were centrifuged at 15,000 x g for 10 minutes
at 4°C. The supernatant was collected and then protein
concentration was measured using the Bio-Rad protein
assay (Bio-Rad). The proteins were separated by SDS-
PAGE and blotted onto a PVDF membrane (Millipore).
The antibodies used are listed in Additional file 1: Table S1.
Isolation of RNA, reverse transcriptase-PCR, and
quantitative real-time-PCR
Total RNA was isolated from A549 cells stimulated with
TGF-β (5 ng/ml) for the indicated times using the RNeasy
Mini Kit (Qiagen) according to the manufacturer’s instruc-
tions. One ug of RNA was reverse transcribed with the
Takara PrimeScript RT Reagent Kit (Takara) following
the manufacturer’s protocol to generate cDNA. The cDNA
was used for real-time-PCR using the SYBR Premix
Ex-Taq Kit (Takara) and was performed on a Bio-Rad
CFX96 real-time PCR detection system (Bio-Rad). All
expression data were normalized to β-actin expression
levels. The primers used are listed in Additional file 1:
Table S2.
Genomic DNA extraction
For each time point of EMT, three dishes of cells were
pooled for DNA extraction. Genomic DNA was extracted
with the QIAamp DNA Mini Kit (Qiagen). DNA length
was determined with an Agilent 2100 Bioanalyzer to ensure
DNA integrity. Genomic DNA was then fragmented
using a Gene Machine Hydroshear apparatus (Harvard
Apparatus) at code 12 for 40 cycles. For each time point,
we pooled the DNA together and performed MSCC
library construction and sequencing to guarantee that
the possible changes in DNA methylation induced by
each time-dependent treatment could be detected.
MSCC library construction and second-generation
sequencing
The MSCC libraries were constructed according to the
description of Guo et al. [21] with few alterations. For each
of the five samples (S0h, S4h, S12h, S24h and S96h),
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that contained a 5′ CG overhang and 3′ NN overhang,
respectively, were created. For the HpaII library, 2 μg
of genomic DNA combined with standard DNA was
digested with HpaII (New England Biolabs [NEB]) for
2 h. Adaptor A was ligated to the resulting fragments.
The reaction products were then incubated with Bst
DNA polymerase (NEB) for 20 min. After digestion with
MmeI (NEB), adaptor B was added to the reaction mixture
incubated with T4 DNA ligase (NEB) overnight. The
products were purified with Agencount AMPure XP
Beads (Beckman) and then run on a 2% E-Gel® EX Gel
(Invitrogen). The target band at approximately 140 bp
was purified with the QIAquick Gel Extraction Kit
(Qiagen). An 8-cycle PCR protocol was performed on the
purification products. For the inverse library, after HpaII
digestion in the first step, the fragmented ends were
deactivated by incubation with Antarctic Phosphatase
(NEB). The products were digested with MspI and then
treated with the same procedure as the HpaII library.MSCC sequencing and data analysis
First, the MSCC libraries were pooled. A total of two lanes
of sequencing was performed on an Illumina HiSeq2000
sequencing system. The sequencing reads contain an
18-bp ‘tag’ and part of the sequence of Adaptor A. The
index sequences within Adaptor A were used to distinguish
different MSCC libraries (Additional file 1: Table S3).
For each library, after adaptor removal, the 18-bp tags
were mapped to the dataset of all possible 18-bp tags in
the human genome (hg19) using MOM software [22].
Reads were accepted if they were uniquely mapped to
the dataset with less than 2 mismatches. For each CCGG
site, sequencing reads from the HpaII library came from
the CCGG sequence, and those from the inverse library
came from the CmCGG or ChmCGG sequence. The data
are summarized in Additional file 1: Table S4. After nor-
malizing the number of reads in both libraries by the
counts of standard DNA, the methylation level of each site
was calculated. The sequenced sites were then mapped to
known genes and CGIs using relevant tables downloaded
from the UCSC genome browser (http://genome.ucsc.edu/).Analysis of gene expression data
The gene expression data for the A549 cell line was ob-
tained from GEO DataSets (http://www.ncbi.nlm.nih.gov/
geo/, (GEO accession GSE17708)). The expression data of
more than 20,000 genes was used for our analysis. For
each gene, the average of the expression data resulting
from all corresponding probes was defined as the expres-
sion level. The expression data at the 0 h (0 hour) time
point was used for analysis in our study.Histone modification and short RNA sequencing data
The histone modification and short RNA sequencing data
were downloaded from GEO DataSets (GEO accession
GSE35583 and GSM897083). The broad peaks of histone
modifications and the locations of short RNAs were
extracted and analyzed.
Statistical analysis
We used 200-bp non-overlapping windows and known
CGIs as units to compare genome-wide DNA methylation.
For each of these units (>3 sequenced CpGs), the average
methylation level of the mapped CpGs was calculated.
A p value was also assigned using Fisher’s exact test by
comparing each unit in different samples.
Results
Morphology of the A549 cell line and characterization
of EMT
A549 human lung cancer cells exhibited a pebble-like
shape. After induction with TGF-β for 1 day and 4 days,
the A549 cells gradually changed from an epithelial to
elongated mesenchymal phenotype (Figure 1a). The pheno-
typic change was accompanied by a progressive loss of
epithelial markers and gain of mesenchymal markers.
At both the protein and mRNA levels (Figure 1b,c), the
expression of E-cadherin was downregulated and the
expression of N-cadherin, Snail1 and Vimentin was upreg-
ulated. After treating A549 cells with TGF-β for 4d, we
found that the cells were substantially elongated and the
expression of E-cadherin had reduced to near-zero levels
(Figure 1a,b,c). Thus, we chose the 4 d time point for our
post-EMT sample and analyzed a total of 5 time points
(S0h, S4h, S12h, S24h and S96h) in the following study.
Global properties of DNA methylation in the A549
cell line
The sequencing depth of each CCGG site significantly
impacts the estimation of DNA methylation levels
(Additional file 1: Figure S1), as Guo et al. [21] has
described. To ensure accuracy and adequate CG coverage
in all 5 samples, we chose CCGG sites with more than 30
sequencing reads for the following analysis. The selected
sites were mapped to known human genes. The majority
of the sites are located in introns and intergenic regions
(Figure 2a). Additionally, due to the randomness of
second-generation sequencing, the distribution of CCGG
sites with 30+ reads was very similar to that of all the
CCGG sites in the human genome. Furthermore, ac-
cording to the data of Guo et al., the distribution of
CCGG sites corresponded to all CG sites; thus, the
methylation of sites with 30+ reads may well reflect
the genome-wide methylation status.
From chromosomal analysis, we found that most chro-
mosomes had similar overall methylation levels, while
Figure 1 Characteristics of the A549 cell line before and after EMT. (a) The morphology of A549 cells treated with TGF-β (5 ng/ml) for
different time intervals was visualized by phase-contrast microscopy (Olympus). (b) The expression of E-cadherin, N-cadherin, Vimentin, and Snail
in TGF-β-treated A549 cells was analyzed by western blotting. (c) mRNA extracted from A549 cells treated with TGF-β was analyzed by RT-PCR
(E-cadherin is shown on the left y-axis, and N-cadherin, Vimentin, and Snail1 are shown on the right y-axis).
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were hypermethylated (Additional file 1: Figure S2).
The calculated methylation levels of CCGG sites were
plotted based on the relative positions of the nearby
genes (Figure 2b). The moving average is also shown.
Most of the positions had similar average methylation
levels except for the regions surrounding the TSS
(transcription start site), which were poorly methylated.
The analyzed sites were also mapped to known CGIs
and CGI shores. Approximately one half of the sites were
located in CGIs or CGI shores (Figure 2c). As expected,
the CCGG sites within CGIs showed significantly lower
overall methylation levels compared to those located
outside of CGIs (Figure 2d). In addition, CGI shores
showed intermediate methylation levels.
The methylation pattern of A549 cells is closely related to
gene expression, histone modification status and short
RNA coding regions
First, we studied the effect of DNA methylation levels
in different regions of genes on gene expression. The
expression data of more than 20,000 genes of the A549
cell line were used. The genes were divided into three
groups in accordance with gene expression level. The
methylation levels of genes with hypo-, semi- and hyperex-
pression levels were analyzed. As shown in Figure 3a, the
three groups of genes exhibited similar DNA methylationdistribution; however, there were significant differences
between the three groups in DNA methylation in TSS
regions and gene bodies. Genes with high expression
levels had the lowest methylation levels near the TSS and
highest methylation levels in the latter half of the gene
body (Figure 3a and b). The situation for genes with low
expression levels was just the opposite. The distribution of
methylation and expression level of genes may influence
each other. The top 20 genes with the highest and lowest
average methylation levels around the TSS region are
listed in Additional file 1: Table S5.
We then considered the relationship between histone
modifications and DNA methylation. The CCGG sites
were mapped according to relative location to the peaks
of two types of histone acetylation and eight types of
histone methylation. The overall methylation level of sites
within and without the peaks of each type of histone
modification was compared. We found that histone acetyl-
ation, including H3K9ac and H3K27ac, has significant
influence on DNA methylation levels. CCGG sites within
histone acetylation peaks had lower levels of methylation
compared to those without the peaks (Figure 3c). There
was also a close relationship between histone methylation
and DNA methylation. Peaks of histone methylation,
including H2az, H3K4me1, H3K4me2, H3K4me3 and
H3K79me2, showed lower DNA methylation levels than
the regions of the genome lacking these histone modifica-
tions. However, peaks of H3K9me3 and H3K27me3 had
ab
c d
Figure 2 Global properties of DNA methylation in the A549 cell line. (a) The distribution of all CCGG sites and those with more than 30 reads.
CCGG sites with 30+ reads are similarly distributed with all CCGG sites. (b) The distribution of CCGG methylation levels from the perspective of genes
(hollow dots). The black line shows the moving average methylation level. (c) The CCGG sites with 30+ reads were mapped to CGIs and CGI shores.
More than half of the CCGG sites are located in CGIs or CGI shores. (d) Overall methylation levels of the CCGG sites located in the respective regions.
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a very weak effect on DNA methylation (Figure 3c). It
is likely that histone modifications may serve as marks
of DNA methylation.
Short total RNA (RNAs shorter than 200 nucleotides)
sequencing data were also analyzed. Only 0.9% of CCGGsites were located in short RNA coding regions, while a
large percentage (21.4%) were within 2000 bp upstream or
downstream of the coding regions (Figure 3d). We noticed
that short RNA coding regions and nearby regions had
lower DNA methylation levels than the other regions




Figure 3 DNA methylation levels closely correlate with gene expression, histone modification and short RNA expression. (a) The
methylation level of genes with high (red line), medium (orange line) and low (blue line) expression levels. (b) The TSS region and latter half of
the gene body show differential DNA methylation levels that correspond to gene expression level. (c) Comparison of DNA methylation levels
within and without differentially histone bound regions. The histone modifications analyzed include histone acetylation and methylation. (d) The
percentage of CCGG sites located in and near short RNA coding regions. (e) The overall methylation level of CCGG sites that are within, near and
without short RNA coding regions.
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occurring via specific mechanisms.
After EMT, the whole DNA methylome was unchanged
Because adjacent CG sites always have similar DNA methy-
lation levels and to avoid the discovery of false positives,
we first scanned the genome using 200-bp consecutive
non-overlapping windows to find differentially methylated
regions. For each 200-bp window (> 3 CpGs involved), the
average methylation level was compared between A549
cells before and after EMT. A p value was also assigned
using Fisher exact tests. Using a cutoff of 25%, few 200-bp
windows with changes in methylation were found in
the S4h, S12h, S24h and S96h treatment groups among
all of the > 10,000 200-bp windows analyzed (Figure 4a).
The average methylation levels of 200-bp windows from
several randomly selected genomic regions in the S24h
compared with S0h groups are shown in Figure 4b. After
treatment with TGF-β, the whole-genome methylation
status of A549 cells was unchanged.
We also analyzed the effect of TGF-β-induced EMT
on the methylation status of CGIs in the genome ofA549 cells. The average methylation level of more
than 10,000 CGIs was calculated and compared be-
tween S4h, S12h, S24h, S96h and S0h. We found that
the genome-wide DNA methylation pattern was un-
changed. No CGI consistently showed a >25% change
in methylation after the cells were treated with TGF-β
for different times (Figure 4a). The methylation levels
of 100 CGIs that had the highest, lowest and inter-
mediate methylation levels in primary A549 cells are
shown in Figure 4c. From the above data, TGF-β-
induced EMT has no effect on the methylation status
of genomic CGIs.
Changes in the whole methylome were also considered
at the single-base level. The methylation levels of all the
CCGG sites in S4h, S12h, S24h and S96h were closely
correlated with those in S0h (Additional file 1: Figure S3).
Additionally, among the approximately 160,000 CCGGs
quantified in S0h, S4h, S12h, S24h and S96h (Additional
file 2: Table S6), almost no CpGs (<0.1%) had a consist-
ent > 25% methylation change in the treated samples.




Figure 4 Comparison of genome-wide DNA methylation of A549 cells before and after EMT. (a) The average methylation level of 200-bp
windows (violet red dots) and CGIs (cyan dots) of S4h, S12h, S24h and S96h compared with S0h. A 25% difference boundary line is shown (black line).
(b) Example regions to show that the average methylation level of the 200 bp windows is similar in S0h (blue line) and S24h (violet red line). (c) The
average methylation level of CGIs that were hypo-, semi- and hypermethylated in primary A549 cells. The data of 100 CGIs are shown as examples.
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methylation-related enzymes
We then studied whether TGF-β-induced EMT influ-
ences histone methylation levels and the expression of
methylation-related enzymes at the protein level. We found
that DNMT1, DNMT3a and DNMT3b were significantly
downregulated, and TET1 was significantly upregulated.
Low expression levels of TET2 and TET3 were observed
and conserved during EMT. We also noticed that the level
of H3K4me3 and H3K9me2 histone methylation in A549
cells was significantly reduced after co-stimulation with
TGF-β for 96 h. However, the level of H3K36me3 was
increased in S96h (Figure 5).
Discussion
Lung cancer metastases are common in people living with
lung cancer and significantly contribute to lung cancer
death [5]. EMT is believed to play crucial roles in cancer
metastasis [6]. In the present study, we analyzed a
genome-wide DNA methylation profile and studied the
relationship between TGF-β-induced EMT and the whole
DNA methylome in lung cancer cells. We report the
global methylation signature of A549 cells and its rela-
tionship with gene expression, histone modifications and
short RNA coding regions. Furthermore, our data provide
evidence that TGF-β-induced EMT had almost no effect
on the global DNA methylome. Notably, we found that
expression of DNMTs and TETs were altered after EMT.
Additionally, histone methylation modifications including
H3K4me3, H3K9me2 and H3K36me3, which were dem-
onstrated to have a role in the EMT of AML12 cells [20],
were also changed during cancer cell EMT in our study.Figure 5 Expression of methylation-related enzymes and
histone methylation levels in A549 cells before and after EMT.
Changes in DNMTs, TETs and several types of histone methylation
after TGF-β treatment over different time intervals were examined by
Western blotting.TGF-β-induced rapid senescence of A549 cells has long
been noticed [23-25]. Detection of cell markers including
E-cadherin, N-cadherin, Snail1 and Vimentin has been
used to identify typical EMT processes [26]. TGF-β
induces changes in these cell markers and cell shape
by activating diverse downstream pathways [27-29].
According to our data, after TGF-β treatment, A549
cells showed characteristics of EMT.
From the methylation signature of the A549 cell line,
we observed low methylation levels at the TSS region of
the genes. This may be due to the lack of nucleosomes,
which are required substrates of de novo methylation, at
active TSSs [11,30]. A low overall methylation level of
CGIs in A549 cells was also found. CGIs are protected
from methylation through two possible mechanisms:
recognition of common cis-acting sequences [31,32] and
active demethylation [33]. The relationship between DNA
methylation and gene expression has long been consid-
ered. Methylation in the immediate vicinity of the TSS
blocks the initiation of gene expression, and high gene
expression levels may also in turn block de novo methyla-
tion of the promoter [34]. The genes with the lowest
average methylation levels around the TSS included
FANCD2, FAM58A, HDAC1, and C14orf166 according
to our data, and FCGBP, CAPN12, FES, and CBLC had
the highest average TSS methylation levels in A549 cells.
Higher methylation within the gene body of genes with
hyperexpression was also found in the present study. It
has been proposed that transcriptional elongation may
stimulate DNA methylation and that H3K36me3, which is
also associated with elongation, might be involved in the
recruitment of DNMTs [35].
The methylation signature of the genome is also closely
correlated with many histone modifications, and we ob-
served an effect of histone acetylation and methylation
on CCGG methylation. It has been found that acetylated
histones are associated with open chromatin, and unmethy-
lated DNA tends to get repackaged into an open con-
figuration. Conversely, non-acetylated histones are often
associated with compact chromatin and methylated DNA
[12,36,37]. Different types of histone methylation also
serve as marks for the genome-wide DNA methylation
pattern. An inverse relationship between H3K4me and
H2az histone marks and DNA methylation has long been
considered [30,38], and here, we report that H3K79me2
is anti-correlated with CCGG methylation. Additionally,
H3K9me3 and H3K27me3 have been found to be repres-
sive marks of gene transcription and positively correlated
with DNA methylation by interacting with methylated
DNA-binding proteins [39-41]. Furthermore, our data
indicate that DNA methylation might be associated with
short RNA expression.
In A549 cells undergoing EMT, we found that there
was no genome-wide DNA methylation reprogramming,
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H3K26me3. The regulation of gene expression by histone
modifications and DNA methylation has long been con-
sidered [42-45]. Histone modifications provide unstable
transcriptional repression, and DNA methylation serves as
a highly stable silencing mark that is not easily reversed
[16]. During just 4 days of A549 cell treatment with TGF-
β, the status of histone modifications was easily changed.
However, DNA methylation remains relatively stable and
cannot be altered in a short time, while the expression of
DNMTs and TETs was regulated according to our data.
The altered expression levels of the genes during and after
EMT that were found by Sartor et al. [46] may not have
been induced by altered DNA methylation but by altered
histone modifications.
In the present study, we quantified the methylation
levels of approximately 300,000 CCGG sites, which is
approximately 13% of all CCGG sites and 1.1% of all CG
sites in humans; thus, the methylation status of other
CG sites and non-CG sites were not included. Although
the methylation levels of the CCGG sites sequenced in
our study could well reflect the methylation status of
all CG sites, the employment of some higher throughput
DNA methylation methods, for example, reduced repre-
sentation bisulfite sequencing (RRBS) and whole-genome
bisulfite sequencing (WGBS), may further confirm our
findings. We tested for changes in whole histone methyla-
tion levels during EMT, and ChIP-Seq technology will
help generate high-resolution profiles of histone modifica-
tions and allow more detailed study of the role of histone
modifications in EMT of cancer cells. Additionally, more
detailed molecular biology research may provide informa-
tion regarding the direct role of DNMTs and TETs in
EMT. In summary, our work explored the genome-wide
DNA methylation signature of A549 lung cancer cells and
the influence of EMT on the epigenome. Although the
exact role of DNMTs, TETs and histone modifications
in TGF-β-induced EMT and whether the levels of these
influence genome-wide DNA methylation over longer
periods of time were not determined, our findings may
contribute to the uncovering of the epigenetic mechanisms
of EMT in cancer cells and benefit the development of
cancer metastasis treatments.
Conclusions
We investigated the whole DNA methylome of cancer
cells during EMT for the first time, and we found that
DNA methylation-related enzymes and histone methylation
might have a role in TGF-β-induced EMT without affecting
the whole DNA methylome of cancer cells. Our data
provide new insights into the global methylation signature
of lung cancer cells and the role of DNA methylation
in EMT and may benefit the development of cancer
metastasis treatments.Additional files
Additional file 1: Figure S1. The effect of sequencing depth on the
accuracy of methylation level estimation. For each level of sequencing
depth, the methylation of all the CCGG sites involved was showed (S0h
on x-axis and S24h on y-axis). As the sequencing depth increases the
Pair-wise correlation coefficient increases, which indicates that the
sequencing data is more believable. Figure S2. The overall methylation
of each chromosome of primary A549 cells. The mitochondrial genome
and Y chromosome show significantly high methylation level. The average
methylation level of other chromosomes is approximately 20%. Figure S3.
The methylation level of CCGG sites with 30+ reads in S4h, S12h, S24h and
S4d compared with S0h. The Pair-wise correlation coefficients are showed
and a similarity between cells before and after EMT is observed. Table S1.
List of antibodies used for western blot. Table S2. List of primers used for
qRT-PCR. Table S3. List of Index used in second-generation sequencing.
Table S4. Summary of second-generation sequencing data in MSCC-seq.
Table S5. The top 20 genes with the highest and lowest average methylation
level around TSS region.
Additional file 2: Table S6. The methylation level and annotation
information of CCGGs quantified both in S0h, S4h, S12h, S24h and S4d.
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